The patient, R.C., finished her chemotherapy for breast cancer on June 4, 2007. At 58, she was ready for a better year, putting cancer treatment behind her and beginning her new life after cancer. In 2014, I was surprised to see R.C. on the schedule for chemotherapy education for FOLFOX (leucovorin...

The radioactive properties of radon have been known for decades, but the risks of exposure have been understated in most professional healthcare curriculums. Healthcare providers in areas with low levels of radon exposure may not consider radon to be a main source of concern in the development of...

Background: Tumor lysis syndrome (TLS) is a potentially fatal complication in patients with large, rapidly proliferating tumor cell cancers that may occur after chemotherapy. Patients with TLS are complicated to treat and often have an unpredictable trajectory. Objectives: The purpose of this...

The purpose of this article is to describe a peer-to-peer program and the outcomes of interventions to reduce the incidence of central line–associated bloodstream infections in patients in bone marrow transplantation, medical, and surgical oncology units. The article reviews the process and...